Moreover, Ugonin M inhibits not only NF‐κB and MAPK activation but also TLR4 protein expression.4 These findings demonstrate that Ugonin M might exert efficacy on LPS‐induced lung infection and is the most effective component of H zeylanica used in pneumonia therapy. Here, TLR4 is linked to pneumonia.